论文部分内容阅读
目的:观察中药心通1～3号方对冠状动脉支架置入术后患者冠脉再狭窄的影响。方法:采用单盲随机分组法将2008年12月至2010年12月冠脉支架术后的患者分为单纯西药组和中西医结合组。西药组采用支架术后常规疗法,中西医结合组服用按辨证自拟的心通1～3号方。治疗6个月后冠脉造影复查冠脉再狭窄程度和统计疗效。结果:西药组与中西医结合组均能降低支架术后冠脉再狭窄的发生,但中西医结合组疗效优于西药组(P<0.05)。结论:心通1～3号方对支架术后的患者冠脉再狭窄能够起到很好的预防作用。
Objective: To observe the effect of Xintong No.1-3 on coronary restenosis after coronary stenting. Methods: The single-blind randomized group of patients from December 2008 to December 2010 after coronary stent were divided into simple western medicine group and traditional Chinese and western medicine combined group. Western medicine group using conventional therapy after stent, combined with traditional Chinese medicine group according to dialectical self-Xin Tong 1 to 3 side. Coronary angiography 6 months after coronary angiography restenosis severity and statistical effect. Results: Western medicine combined with traditional Chinese and Western medicine can reduce the incidence of coronary artery stenosis after stent implantation, but the effect of traditional Chinese medicine and Western medicine combination group is better than western medicine group (P <0.05). Conclusion: Xintong No.1 and No.3 prescription can prevent coronary artery restenosis in patients after stenting.